Sign in

CIK 0001721484

  • Emerging growth company

Longeveron Inc.

Sign in to watch
Ticker
LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472174146
Phone
+1 305-302-7158
Business address
1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
Former names
LONGEVERON LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 14 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-02 Hashad Mohamed Wa'el Ahmed Chief Executive Officer Shares withheld for taxes −5,123 $1.32 $7K 42,443
2024-01-02 Agafonova Nataliya Chief Medical Officer Shares withheld for taxes −3,074 $1.32 $4K 20,786
2024-01-02 Lehr Paul T General Counsel, Secretary Shares withheld for taxes −992 $1.32 $1K 142,406
2023-12-29 Baluch Khoso Director Purchase +8,322 $1.43 $12K 15,000
2023-12-28 Baluch Khoso Director Purchase +1,678 $1.40 $2K 6,678
2023-12-28 PFEFFER JEFFREY Director Purchase +10,000 $1.35 $14K 15,000
2023-12-21 Ross Cathy Director Grant or award · Stock Option (Right to buy) +12,000 12,000
2023-12-21 LOSORDO DOUGLAS W Director Grant or award · Stock Option (Right to buy) +12,000 12,000
2023-12-21 Hare Joshua Chief Scientific Officer Grant or award · Stock Option (Right to buy) +12,000 12,000
2023-12-21 Soffer Rock Director Grant or award · Stock Option (Right to buy) +12,000 12,000
2023-12-21 Ungaro Ursula Director Grant or award · Stock Option (Right to buy) +12,000 12,000
2023-12-21 Hare Neil E Director Grant or award · Stock Option (Right to buy) +12,000 12,000
2023-12-21 Baluch Khoso Director Grant or award · Stock Option (Right to buy) +12,000 12,000
2023-12-21 PFEFFER JEFFREY Director Grant or award · Stock Option (Right to buy) +12,000 12,000
2023-10-02 Lehr Paul T General Counsel, Secretary Shares withheld for taxes −815 $2.29 $2K 143,398
2023-10-02 Locklear Lisa Chief Financial Officer Shares withheld for taxes −4,078 $2.29 $9K 40,922
2023-10-02 Agafonova Nataliya Chief Medical Officer Shares withheld for taxes −3,059 $2.29 $7K 23,860
2023-09-21 Hare Joshua Chief Scientific Officer Option exercise +5,000 $3.00 $15K 7,828,263
2023-09-21 Hare Joshua Chief Scientific Officer Option exercise · Subscription Rights (right to buy) −5,000 39,191,771
2023-09-20 Lehr Paul T General Counsel, Secretary Option exercise +2,000 $3.00 $6K 144,213

Page 8 of 14 · 271 trades